OncXerna Therapeutics

Advancing a new paradigm of precision oncology with a RNA-based approach to match patients to novel, targeted treatments. Improving lives of people with cancer.

[OncXerna Therapeutics @OncXerna]

Listen to Mark Uhlik, Ph.D., present on the Xerna TME Panel and data recently presented at ESMO at QIAGEN’s Innovation Forum 2022! #cancerresearch

https://t.co/Q5UC454Rt7

[OncXerna Therapeutics @OncXerna]

Today at @myESMO (ESMO), we announced new Xerna™ TME Panel Biomarker Data from Retrospective Analysis of Results from a Randomized Phase 2 Trial Evaluating Anti-PD-1 Maintenance Therapy in Esophagogastric Adenocarcinoma. Read more https://t.co/3l8JYZUJ4P.

[OncXerna Therapeutics @OncXerna]

We’re excited to announce our first patient dosed in a Phase 2 basket trial of navicixizumab! Read more at https://t.co/6tRUC0PGAc

[OncXerna Therapeutics @OncXerna]

Be sure to check out article in Nature Biopharma Dealmakers, just released today!

https://t.co/g9xRZoooNt

#ai #artificialintelligence #medicine #pipeline #biopharma

[OncXerna Therapeutics @OncXerna]

OncXerna Therapeutics supports the @MensHlthNetwork in their goal to increase awareness of men’s health issues on a global level. Talk to your healthcare provider about scheduling the appointments you need to keep yourself in good health! #MensHealthWeek

[OncXerna Therapeutics @OncXerna]

OncXerna Therapeutics congratulates Dr. Elizabeth Gerstner from Mass General Cancer Center on poster presented at @ASCO. Read more here: https://t.co/yIKUiOTkqw, https://t.co/3sNQa6vYb4 #ASCO22 #glioblastoma #bavi

[OncXerna Therapeutics @OncXerna]

OncXerna Therapeutics celebrates and appreciates the hard work and compassion of oncology nurses! @oncologynursing #OncologyNursingMonth

[OncXerna Therapeutics @OncXerna]

OncXerna Therapeutics would like to thank all the investigators, site personnel, patients, and families that participate in cancer research!
#NationalCancerResearchMonth #NCRM22 #ClinicalTrialsDay #CTD2022

[OncXerna Therapeutics @OncXerna]

OncXerna Therapeutics wants to expand awareness for ovarian cancer and recognize World Ovarian Cancer Day.
#WorldOvarianCancerDay #OvarianCancerAwareness #OvarianCancer #WOCD2022

[OncXerna Therapeutics @OncXerna]

It was great to have the entire team in Waltham this past week!
#team #teammeeting #teambonding

[OncXerna Therapeutics @OncXerna]

Today, Laura Benjamin, PhD, will be at the 12th Annual Clinical Biomarker and CDx Europe Summit in London.
@WorldCDx #PrecisionMedicine #Biomarker

[OncXerna Therapeutics @OncXerna]

OncXerna Therapeutics is proud to announce @JCO_ASCO publication featuring Phase 1b data of navicixizumab plus paclitaxel in ovarian cancer.
Read more here: https://t.co/IZjumGvo28, https://t.co/D4gYtVgHyR
#OvarianCancer #XernaTME #navi

[OncXerna Therapeutics @OncXerna]

Today in Washington, DC at the #WorldVaccineCongress, OncXerna's Founder/CEO, Laura Benjamin, PhD, will moderate a keynote panel on advances in precision medicine tools informing strategies for mono and combination therapies. #WVCDC #WVCUSA #PrecisionMedicine @VaccineNation

[OncXerna Therapeutics @OncXerna]

Please join us in celebrating OncXerna Therapeutics’ 4-year anniversary!
#PrecisionMedicine #CompanyAnniversary

[OncXerna Therapeutics @OncXerna]

OncXerna Therapeutics highlights the Xerna™ TME Panel’s prognostic and predictive value across indications and therapeutic classes at the AACR Annual Meeting. Read more here: https://t.co/ucMmZ3s5PU @AACR #AACR22 #AACR2022 #XernaTMEPanel

[OncXerna Therapeutics @OncXerna]

March is National Colorectal Cancer Awareness Month. With regular screening, most polyps can be found and removed before they turn into cancer. Early detection leads to better outcomes! #ColorectalCancerAwarenessMonth #ColonCancerAwareness #ColonCancer #CancerAwareness

[OncXerna Therapeutics @OncXerna]

March 18-21, Kerry Culm, Ph.D., Vice President of Clinical Development at OncXerna Therapeutics, will present at the 2022 Annual Meeting on Women’s Cancer hosted by @SGO_org in Phoenix, Arizona. View our poster here: https://t.co/HcbMFZ55Rd #SGO #SGOmtg #WomensCancer

[OncXerna Therapeutics @OncXerna]

Celebrating the women of OncXerna Therapeutics on International Women’s Day! #InternationalWomensDay #InternationalWomensDay2022

[OncXerna Therapeutics @OncXerna]

Today, March 3ʳᵈ, OncXerna Therapeutics’ Head of Research and Biomarker Discovery, Mark Uhlik, will be presenting at the 3ʳᵈ Annual Oncology Research Information Exchange Network (ORIEN) Scientific Retreat hosted by @M2GEN in St. Pete Beach, FL.
#PrecisionMedicine #Oncology

[OncXerna Therapeutics @OncXerna]

We're excited to share that StartUs Insights evaluated 479 companies globally and recognized OncXerna Therapeutics as one of the top 5 precision medicine startups. Read more here: https://t.co/X5LXQMJOqi #PrecisionMedicine